CClinicalTrials.gg
CompletedNCT04162184Updated Aug 12, 2024

Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder

An interventional study of Sexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention in Family Planning Services, Substance-Related Disorders and Opiate Substitution Treatment, sponsored by Denver Health and Hospital Authority. Completed at 1 site in United States. Open to participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-12.

Sponsored by Denver Health and Hospital Authority · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
199
Allocation
Not applicable
Ages
18 Years to 44 Years
Sex
All
01

Study summary

This study will utilize mixed methods to develop and assess the feasibility and acceptability of a health educator intervention designed to connect patients in recovery from substance use disorder to reproductive health education and services.

Read the detailed description

Developing effective reproductive health interventions for individuals in treatment for substance use disorder is an important public health priority. In the US nearly half (45%) of all pregnancies are unplanned and studies have consistently found this rate to be much higher among individuals in substance treatment, almost 90%. There is a paucity of research on interventions to support the family planning care of this population. The primary goal of this project is to identify an innovative delivery model to address the family planning needs of individuals of reproductive age in treatment for substance use disorder at an urban integrated safety-net health system. Through the use of mixed methods this study will address the following objectives: 1) To describe the family planning experiences and needs of individuals in treatment for substance use disorders (SUD) in a representative sample of patients and 2) To assess the feasibility and acceptability of the intervention among study participants. If found to be acceptable, efficacy should be assessed in a randomized controlled trial. A navigator model such as this is generalizable and could be easily integrated into a variety of settings.

02

Conditions studied

  • Family Planning Services
  • Substance-Related Disorders
  • Opiate Substitution Treatment
  • Sexual Health

Keywords

  • family planning
  • opioid use disorder
  • patient navigation
  • reproductive health
  • sexual health
  • substance use disorder
  • health education
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 199 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Denver Health and Hospital Authority is the lead sponsor of 84 studies on the registry; 4 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • In treatment for substance use disorder at one of the participating clinics; 18-44 years of age; English-speaking; not currently pregnant; able to become pregnant (e.g., no history of hysterectomy, tubal ligation, hysterectomy, menopause); not planning to leave the Denver area in the next 3 months.

Exclusion criteria

Exclusion Criteria:

  • currently pregnant; intoxicated or mentally impaired to the point that one is unable to voluntarily consent to participate and/or respond to the surveys.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
199 participants (actual)

Study arms

  • Other
    Health Educator Intervention

    As the population of focus in this study is diverse, including men and women regardless of pregnancy desire, the primary focus for the intervention for this study will be education, particularly for men. All participants that enroll in the study will be offered the intervention. The study health educator will use the PATH (Parenthood/Pregnancy Attitude, Timing, and How) framework questions to initially guide the conversation. Depending on the participant's desires, the educator will provide education on other topics such as sexually transmitted infections (STIs) and we will also navigate to clinical services as needed. The health educator will use a study manual to guide all intervention activities including engagement. Additionally, the health educator will collect data on intervention outreach, engagement, topics discussed, participant needs and outcomes.

    Behavioral: Sexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention

Interventions

  • BehavioralSexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention

    a brief health educator-led behavioral intervention focused on educating, identifying reproductive health needs, and linking to services if desired

    Also known as: SHINE Intervention

06

What researchers measure

Primary outcomes

  1. Intervention sessions completed.

    Intervention acceptability will be measured by the number of sessions completed by the health educator among participants enrolled in the study.

    Time frame: up to 3 months

  2. Self-reported satisfaction with intervention.

    Intervention acceptability will be assessed by participant self-reported satisfaction with the intervention (via surveys) among those who complete the intervention sessions. Satisfaction will be assessed with 8 items on a 4-point scale describing how strongly participants agree with each statement. The response scale is coded so that a higher score reflects higher satisfaction and therefore a better outcome. Reported as mean overall score (range 1-32).

    Time frame: up to 3 months

07

Study locations

1 site
  • Denver Health & Hospital Authority
    Denver, Colorado 80204, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04162184
Lead sponsor
Denver Health and Hospital Authority
Collaborators
Department of Health and Human Services
Responsible party
Deborah Rinehart (Research Scientist, Denver Health and Hospital Authority) — Principal investigator
First posted
Nov 14, 2019
Start date
Dec 16, 2019
Primary completion
Jan 30, 2023
Completion
Sep 30, 2023
Last update
Aug 12, 2024

Study contacts

Deborah Rinehart, PhD, MA
principal investigator · Denver Health & Hospital Authority

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion